Literature DB >> 30635896

Computational Resources for Prediction and Analysis of Functional miRNA and Their Targetome.

Isha Monga1, Manoj Kumar2.   

Abstract

microRNAs are evolutionarily conserved, endogenously produced, noncoding RNAs (ncRNAs) of approximately 19-24 nucleotides (nts) in length known to exhibit gene silencing of complementary target sequence. Their deregulated expression is reported in various disease conditions and thus has therapeutic implications. In the last decade, various computational resources are published in this field. In this chapter, we have reviewed bioinformatics resources, i.e., miRNA-centered databases, algorithms, and tools to predict miRNA targets. First section has enlisted more than 75 databases, which mainly covers information regarding miRNA registries, targets, disease associations, differential expression, interactions with other noncoding RNAs, and all-in-one resources. In the algorithms section, we have compiled about 140 algorithms from eight subcategories, viz. for the prediction of precursor (pre-) and mature miRNAs. These algorithms are developed on various sequence, structure, and thermodynamic based features incorporated into different machine learning techniques (MLTs). In addition, computational identification of miRNAs from high-throughput next generation sequencing (NGS) data and their variants, viz. isomiRs, differential expression, miR-SNPs, and functional annotation, are discussed. Prediction and analysis of miRNAs and their associated targets are also evaluated under miR-targets section providing knowledge regarding novel miRNA targets and complex host-pathogen interactions. In conclusion, we have provided comprehensive review of in silico resources published in miRNA research to help scientific community be updated and choose the appropriate tool according to their needs.

Entities:  

Keywords:  Algorithm; Analysis tools; Database; Machine learning tools; Transcription factor; microRNA

Mesh:

Substances:

Year:  2019        PMID: 30635896     DOI: 10.1007/978-1-4939-8982-9_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.

Authors:  Alessia Finotti; Jessica Gasparello; Alessandro Casnati; Roberto Corradini; Roberto Gambari; Francesco Sansone
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Unveiling ncRNA regulatory axes in atherosclerosis progression.

Authors:  Estanislao Navarro; Adrian Mallén; Josep M Cruzado; Joan Torras; Miguel Hueso
Journal:  Clin Transl Med       Date:  2020-02-03

Review 3.  An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease.

Authors:  J Samael Rodríguez-Sanabria; Rebeca Escutia-Gutiérrez; Rebeca Rosas-Campos; Juan S Armendáriz-Borunda; Ana Sandoval-Rodríguez
Journal:  Front Med (Lausanne)       Date:  2022-01-11

Review 4.  MicroRNA let-7 and viral infections: focus on mechanisms of action.

Authors:  Arash Letafati; Sajad Najafi; Mehran Mottahedi; Mohammad Karimzadeh; Ali Shahini; Setareh Garousi; Mohammad Abbasi-Kolli; Javid Sadri Nahand; Seyed Saeed Tamehri Zadeh; Michael R Hamblin; Neda Rahimian; Mohammad Taghizadieh; Hamed Mirzaei
Journal:  Cell Mol Biol Lett       Date:  2022-02-14       Impact factor: 5.787

Review 5.  miRNA therapeutics in precision oncology: a natural premium to nurture.

Authors:  Chakresh Kumar Jain; Poornima Srivastava; Amit Kumar Pandey; Nisha Singh; R Suresh Kumar
Journal:  Explor Target Antitumor Ther       Date:  2022-08-31

6.  MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cells.

Authors:  Hengxiao Lu; Hao Wang; Peidao Sun; Jiang Wang; Shuhai Li; Tongzhen Xu
Journal:  Cytotechnology       Date:  2021-05-07       Impact factor: 2.040

7.  Demonstrating specificity of bioactive peptide nucleic acids (PNAs) targeting microRNAs for practical laboratory classes of applied biochemistry and pharmacology.

Authors:  Jessica Gasparello; Chiara Papi; Matteo Zurlo; Roberto Corradini; Roberto Gambari; Alessia Finotti
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.